1. Volume 58, Issue 2, Pages 762-769 (August 2000)
Long-term comparison of losartan and enalapril on kidney function in hypertensive type 2 diabetics with early nephropathy 
Yves Lacourcière, André Bélanger, Chantal Godin, Jean-Pierre Hallé, Stuart Ross, Noël Wright, Jean Marion 
Kidney International 
Volume 58, Issue 2, Pages (August 2000)
DOI: /j x
Copyright © 2000 International Society of Nephrology Terms and Conditions

2. Figure 1
Urine albumin excretion in the losartan (▪) and enalapril (○) groups. Both treatments induced significant reductions from baseline in albuminuria at either 12, 28, or 52 weeks of therapy. Error bars represent 95% confidence intervals. *P = 0.027; **P < vs. baseline.
Kidney International  , DOI: ( /j x)
Copyright © 2000 International Society of Nephrology Terms and Conditions

3. Figure 2
Relationship between the changes in ambulatory blood pressure (ABP) and the changes in Log urinary albumin excretion (UAE) for losartan (N = 38; ⋄) and enalapril (N = 40; ×) groups at week 52 is illustrated by the regression lines fitted to the data points of the scatter plot. Losartan (LOS) slope = , Enalapril (ENA) slope = P = 0.69 between groups; r = 0.34, P = for LOS; r = 0.42, P = for ENA (error bars represent 95% confidence units on regression means).
Kidney International  , DOI: ( /j x)
Copyright © 2000 International Society of Nephrology Terms and Conditions

4. Figure 3
Glomerular filtration rate (GFR) in the losartan (▪) and enalapril (○) groups. Both treatments induced a significant reduction from baseline in GFR that plateaued after 52 weeks of therapy. Error bars represent 95% confidence intervals. *P = for losartan; **P < for both losartan and enalapril versus baseline.
Kidney International  , DOI: ( /j x)
Copyright © 2000 International Society of Nephrology Terms and Conditions